Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
78.8M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
12.4M
-
Shares change
-
-933K
-
Total reported value, excl. options
-
$49.3M
-
Value change
-
-$5.64M
-
Put/Call ratio
-
2
-
Number of buys
-
35
-
Number of sells
-
-40
-
Price
-
$4.02
Significant Holders of CorMedix Inc. - Common stock, $0.001 par value (CRMD) as of Q2 2022
97 filings reported holding CRMD - CorMedix Inc. - Common stock, $0.001 par value as of Q2 2022.
CorMedix Inc. - Common stock, $0.001 par value (CRMD) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.4M shares
of 78.8M outstanding shares and own 15.76% of the company stock.
Largest 10 shareholders include NOMURA HOLDINGS INC (2.95M shares), VANGUARD GROUP INC (1.66M shares), Elliott Investment Management L.P. (1.55M shares), BARCLAYS PLC (750K shares), MILLENNIUM MANAGEMENT LLC (686K shares), BlackRock Inc. (638K shares), GEODE CAPITAL MANAGEMENT, LLC (331K shares), Cresset Asset Management, LLC (330K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (282K shares), and BANK OF MONTREAL /CAN/ (282K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.